2021
DOI: 10.11606/s1518-8787.2021055003855
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?

Abstract: The coronavirus disease 2019 (COVID-19) pandemic is significantly causing unprecedented clinical, socioeconomic, and public health challenges globally. The successful global administration of effective, safe and sustainable vaccine(s) is widely believed to be crucial in mitigating as well as preventing COVID-19. However, the rising cases of severe adverse events following immunization (AEFI) with COVID-19 vaccines including thrombosis, thrombocytopenia, and in some instances, death have created serious global … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…Although the rate of allergic reactions for LNP vaccines containing mRNA cargo is generally around 1.31 (95% CI, 0.90-1.84) per million doses, the number of severe immune reactions may be higher with booster doses [117]. LNPs induce inflammation, especially in non-adherent cells, due to the higher availability of cell surface receptors than in adherent cells [118,119].…”
Section: Adverse Effects Associated With Sars-cov-2 Nanoparticle Vacc...mentioning
confidence: 99%
“…Although the rate of allergic reactions for LNP vaccines containing mRNA cargo is generally around 1.31 (95% CI, 0.90-1.84) per million doses, the number of severe immune reactions may be higher with booster doses [117]. LNPs induce inflammation, especially in non-adherent cells, due to the higher availability of cell surface receptors than in adherent cells [118,119].…”
Section: Adverse Effects Associated With Sars-cov-2 Nanoparticle Vacc...mentioning
confidence: 99%
“…Most of the patients detected anti-PSA immune response, especially the increase in the proportion of PSA-specific T cells (148). Of course, the use of viral vaccines may be accompanied by adverse events associated with them (149), including mild adverse reactions (local pain, swelling or induration and systemic fever) and severe adverse reactions (thrombosis and/or allergies) (150,151). However, with the application of covid-19 adenovirus vaccine, biosafety problems may be forced to be solved, which may promote the development of viral vaccines.…”
Section: Microbial Immunotherapy For Prostate Cancermentioning
confidence: 99%